Skip to content

Government belongs to the people.

If it governs your life, you should have a voice in it.

Official voting resourcesVote.gov ↗USA.gov ↗
All federal
19,967 total · sort: latest action
H.R. 10136 · HOUSE1d
Crossett Experimental Forest Act of 2026
Motion to reconsider laid on the table Agreed to without objection.
H.R. 9785 · HOUSE1d
South Dakota Water Feasibility Studies Act
Motion to reconsider laid on the table Agreed to without objection.
H.R. 9640 · HOUSE1d
Earth MRI Reauthorization Act of 2026
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair…
H.R. 9600 · HOUSE1d
Common Sense 250 Act of 2026
Motion to reconsider laid on the table Agreed to without objection.
H.R. 8801 · HOUSE1d
DC ROADS Act
Placed on the Union Calendar, Calendar No. 779.
H.R. 8552 · HOUSE1d
Veterans’ Compensation Cost-of-Living Adjustment Act of 2026
Presented to President.
H.R. 8483 · HOUSE1d
Barona Group of Capitan Grande Band of Mission Indians Land Transfer Act of 2026
Motion to reconsider laid on the table Agreed to without objection.
S. 1353 · SENATE1d
A bill to extend the authority for modifications to the Second Division Memorial in the District of Columbia.
Held at the desk.
H.R. 4930 · HOUSE1d
To expand the sharing of information with respect to suspected violations of intellectual property rights in trade.
Presented to President.
H.R. 5267 · HOUSE1d
American Franchise Act
Rules Committee Resolution H. Res. 1665 Reported to House. Rule provides for consideration of H.R. 3495 and H.R. 5267. The resolution…
H.R. 3495 · HOUSE1d
Direct Seller and Real Estate Agent Harmonization Act
Rules Committee Resolution H. Res. 1665 Reported to House. Rule provides for consideration of H.R. 3495 and H.R. 5267. The resolution…
H.R. 2400 · HOUSE1d
Pit River Land Transfer Act of 2026
Motion to reconsider laid on the table Agreed to without objection.
H.R. 8195 · HOUSE1d
Responsible Cormorant Management and Control Act of 2026
Motion to reconsider laid on the table Agreed to without objection.
S. 5720 · SENATE2d
A bill to amend title 9 of the United States Code with respect to arbitration.
Read twice and referred to the Committee on the Judiciary.
S. 5721 · SENATE2d
A bill to require Federal agency heads to submit an annual assessment on staffing needs of information technology contracting officers and contracting officer's representatives, to require the heads to submit a plan on information technology acquisition workforce staffing and development using the assessments, and for other purposes.
Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
Showing 15 of 19,967Load 50 more →
119th Congress · H.R. 685 · Introduced

SAVE Moms and Babies Act of 2025

Support And Value Expectant Moms and Babies Act of 2025 or the SAVE Moms and Babies Act of 2025 This bill prohibits the Food and Drug Administration (FDA) from approving any new drug (either as a brand-name drug or a generic) intended to terminate a pregnancy and imposes additional restrictions on such drugs that are already approved. Under the bill, an already-approved drug intended to terminate a pregnancy may be dispensed to a patient only with a prescription. Furthermore, the FDA may not approve any labeling change that would authorize (1) using the drug after 70 days of gestation, or (2) dispensing the drug by any means other than in-person administration by the prescribing health care practitioner. The FDA must also impose additional restrictions on such already-approved drugs, including by (1) requiring the prescribing health care practitioner to receive a special certification, (2) prohibiting the practitioner from also acting as the dispensing pharmacist, and (3) requiring the practitioner to have the ability to provide surgical intervention to the patient. The bill also rescinds any investigational use exemption already granted to such a drug if the bill would have prohibited the FDA from granting the exemption. (Currently, the FDA may grant an exemption to certain market approval requirements if a drug is intended solely for use in safety and effectiveness investigations.)

0
Voices Recorded
L3 verified 0
L2 verified 0
Why three axes? · 50-second explainer

1 / 10
Now you know how it works.
Your true verified voice
Your Stance
Should this happen?
0%
0%
0%
Fiscal Judgment
Where do you stand on this government spending?
0%
0%
0%
Authority — Multiple can be selected
Which authority should have control over this? Mark all that apply.
0%
0%
0%
0%
SubjectsAbortionDrug safety, medical device, and laboratory regulationHealth information and medical recordsHealth personnelHealth technology, devices, suppliesMarketing and advertisingPrescription drugs

XML scalars

congress
119
type
HR
number
685
originChamber
House
originChamberCode
H
introducedDate
2025-01-23
updateDate
2026-11-13T09:06:48Z
updateDateIncludingText
2026-11-13T09:06:48Z
title
SAVE Moms and Babies Act of 2025
legislationUrl
https://www.congress.gov/bill/119th-congress/house-bill/685

Constitutional authority statement (CDATA)

[Congressional Record Volume 171, Number 14 (Thursday, January 23, 2025)][House][Pages H388-H389]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. LATTA:H.R. 685.Congress has the power to enact this legislation pursuantto the following:The Constitution grants of powers to Congress under ArticleI, Section 8, Clause 18: To[[Page H389]]make all Laws which shall be necessary and proper forcarrying into Execution the foregoing Powers, and all otherPowers vested by this Constitution in the Government of theUnited States, or in any Department or Officer thereof.

Pipeline

Track
federal_presidential
Stage
Introduced
Stage rank
3

Sponsor

  • Rep. Latta, Robert E. [R-OH-5] · [R-OH-5] · L000566
    Rep-OH-5 current · 10 terms · @BobLatta · 3 district offices

Sponsor record (congress_legislators)

Bio (legislators)

bioguide
L000566
status
current
official_full
Robert E. Latta
first
Robert
middle
E.
last
Latta
suffix
null
nickname
null
birthday
1956-04-18
gender
M

Current term (10 total)

type
rep
state
OH
district
5
class
null
party
Republican
caucus
null
start
2025-01-03
end
2027-01-03
end_type
null
how
null
url
https://latta.house.gov
address
2470 Rayburn House Office Building Washington DC 20515-3505
office
2470 Rayburn House Office Building
phone
202-225-6405
fax
null
contact_form
null
rss_url
http://latta.house.gov/news/rss.aspx

Leadership roles (0)

none

Committee memberships (4)

  • Communications and Technology (house) · house · rank 3
  • Energy (house) · house · Chair · rank 1
  • Environment (house) · house · rank 3
  • House Committee on Energy and Commerce (house) · house · rank 2 · site

Social media

District offices (3)

  • 1045 N. Main St., Suite 6, Bowling Green, OH, 43402 · 419-354-8700 · 41.3891803,-83.65120619999999
  • 318 Dorney Plz., Room 302, Findlay, OH, 45840 · 419-422-7791 · 41.038435,-83.6516735
  • 226 Middle Avenue, 5th Floor, Elyria, OH, 44035 · 440-406-5010 · 41.3656038,-82.10598329999999

Other names (0)

none

Sponsor FEC record (fec_live)

Candidate record (candidates) · cycle 2026

candidate_id
H8OH05036
cycle
2026
name
LATTA, ROBERT EDWARD
party
REPUBLICAN PARTY
office
House
state
OH
district
05
incumbent_challenge
Incumbent
candidate_status
C
active_through
2026
election_year
null
first_file_date
1988-01-21
last_file_date
2025-01-29
last_f2_date
2025-01-29
address
null

Candidate summary (candidate_summaries) · cycle 2026

cycle
2026
total_receipts
$1,461,647.52
total_disbursements
$1,038,449.99
cash_on_hand_end_period
$1,019,992.61
debts_owed_by_committee
$0.00
coverage_start_date
2025-01-01
coverage_end_date
2026-06-30

Connected committees (0)

none

Cosponsors (88)

  • Rep. Rouzer, David [R-NC-7] · [R-NC-7] · R000603 · Co-sponsored 2025-01-23 · original
    Rep-NC-7 current · 6 terms · @RepDavidRouzer · 3 district offices
  • Rep. Brecheen, Josh [R-OK-2] · [R-OK-2] · B001317 · Co-sponsored 2025-01-23 · original
    Rep-OK-2 current · 2 terms · @repbrecheen · 1 district office
  • Rep. Strong, Dale W. [R-AL-5] · [R-AL-5] · S001220 · Co-sponsored 2025-01-23 · original
    Rep-AL-5 current · 2 terms · @RepDaleStrong · 2 district offices
  • Rep. Miller, Mary E. [R-IL-15] · [R-IL-15] · M001211 · Co-sponsored 2025-01-23 · original
    Rep-IL-15 current · 3 terms · @RepMaryMiller · 2 district offices
  • Rep. Webster, Daniel [R-FL-11] · [R-FL-11] · W000806 · Co-sponsored 2025-01-23 · original
    Rep-FL-11 current · 8 terms · @RepWebster · 2 district offices
  • Rep. Finstad, Brad [R-MN-1] · [R-MN-1] · F000475 · Co-sponsored 2025-01-23 · original
    Rep-MN-1 current · 3 terms · @RepFinstad · 2 district offices
  • Rep. Aderholt, Robert B. [R-AL-4] · [R-AL-4] · A000055 · Co-sponsored 2025-01-23 · original
    Rep-AL-4 current · 15 terms · @Robert_Aderholt · 3 district offices
  • Rep. Feenstra, Randy [R-IA-4] · [R-IA-4] · F000446 · Co-sponsored 2025-01-23 · original
    Rep-IA-4 current · 3 terms · @RepFeenstra · 3 district offices
  • Rep. Smith, Christopher H. [R-NJ-4] · [R-NJ-4] · S000522 · Co-sponsored 2025-01-23 · original
    Rep-NJ-4 current · 23 terms · 2 district offices
  • Rep. Fulcher, Russ [R-ID-1] · [R-ID-1] · F000469 · Co-sponsored 2025-01-23 · original
    Rep-ID-1 current · 4 terms · @RepRussFulcher · 3 district offices
  • Rep. Flood, Mike [R-NE-1] · [R-NE-1] · F000474 · Co-sponsored 2025-01-23 · original
    Rep-NE-1 current · 3 terms · @USRepMikeFlood · 1 district office
  • Rep. Mann, Tracey [R-KS-1] · [R-KS-1] · M000871 · Co-sponsored 2025-01-23 · original
    Rep-KS-1 current · 3 terms · @RepMann · 2 district offices
  • Rep. Harris, Andy [R-MD-1] · [R-MD-1] · H001052 · Co-sponsored 2025-01-23 · original
    Rep-MD-1 current · 8 terms · @RepAndyHarrisMD · 3 district offices
  • Rep. Fong, Vince [R-CA-20] · [R-CA-20] · F000480 · Co-sponsored 2025-01-23 · original
    Rep-CA-20 current · 2 terms · @RepVinceFong · 2 district offices
  • Rep. Ellzey, Jake [R-TX-6] · [R-TX-6] · E000071 · Co-sponsored 2025-01-23 · original
    Rep-TX-6 current · 3 terms · @RepEllzey · 2 district offices
  • Rep. Weber, Randy K. Sr. [R-TX-14] · [R-TX-14] · W000814 · Co-sponsored 2025-01-23 · original
    Rep-TX-14 current · 7 terms · @TXRandy14 · 3 district offices
  • Rep. McCormick, Richard [R-GA-7] · [R-GA-7] · M001218 · Co-sponsored 2025-01-23 · original
    Rep-GA-7 current · 2 terms · @RepMcCormick · 1 district office
  • Rep. Moolenaar, John R. [R-MI-2] · [R-MI-2] · M001194 · Co-sponsored 2025-01-23 · original
    Rep-MI-2 current · 6 terms · @RepMoolenaar · 2 district offices
  • Rep. Ogles, Andrew [R-TN-5] · [R-TN-5] · O000175 · Co-sponsored 2025-01-23 · original
    Rep-TN-5 current · 2 terms · @repogles · 1 district office
  • Rep. Guest, Michael [R-MS-3] · [R-MS-3] · G000591 · Co-sponsored 2025-01-23 · original
    Rep-MS-3 current · 4 terms · @RepMichaelGuest · 4 district offices
  • Rep. Higgins, Clay [R-LA-3] · [R-LA-3] · H001077 · Co-sponsored 2025-01-23 · original
    Rep-LA-3 current · 5 terms · @RepClayHiggins · 2 district offices
  • Rep. Palmer, Gary J. [R-AL-6] · [R-AL-6] · P000609 · Co-sponsored 2025-01-23 · original
    Rep-AL-6 current · 6 terms · @USRepGaryPalmer · 1 district office
  • Rep. Moore, Tim [R-NC-14] · [R-NC-14] · M001236 · Co-sponsored 2025-01-23 · original
    Rep-NC-14 current · 1 term · @RepTimMooreNC · 1 district office
  • Rep. Shreve, Jefferson [R-IN-6] · [R-IN-6] · S001229 · Co-sponsored 2025-01-23 · original
    Rep-IN-6 current · 1 term · @repshreve · 3 district offices
  • Rep. LaHood, Darin [R-IL-16] · [R-IL-16] · L000585 · Co-sponsored 2025-01-23 · original
    Rep-IL-16 current · 6 terms · @RepLaHood · 3 district offices
  • Rep. Fitzgerald, Scott [R-WI-5] · [R-WI-5] · F000471 · Co-sponsored 2025-02-11
    Rep-WI-5 current · 3 terms · @RepFitzgerald · 1 district office
  • Rep. Biggs, Sheri [R-SC-3] · [R-SC-3] · B001325 · Co-sponsored 2025-02-11
    Rep-SC-3 current · 1 term · @repsheribiggs · 1 district office
  • Rep. Moore, Barry [R-AL-1] · [R-AL-1] · M001212 · Co-sponsored 2025-09-19
    Rep-AL-1 current · 3 terms · @RepBarryMoore · 5 district offices
  • Rep. Bost, Mike [R-IL-12] · [R-IL-12] · B001295 · Co-sponsored 2025-10-31
    Rep-IL-12 current · 6 terms · @RepBost · 3 district offices
  • Rep. Fedorchak, Julie [R-ND-At Large] · [R-ND-0] · F000482 · Co-sponsored 2026-04-14
    Rep-ND current · 1 term · @RepFedorchak · 2 district offices
  • Rep. Thompson, Glenn [R-PA-15] · [R-PA-15] · T000467 · Co-sponsored 2026-04-14
    Rep-PA-15 current · 9 terms · @CongressmanGT · 2 district offices
  • Rep. Cloud, Michael [R-TX-27] · [R-TX-27] · C001115 · Co-sponsored 2026-04-14
    Rep-TX-27 current · 5 terms · @RepCloudTX · 2 district offices
  • Rep. Hageman, Harriet M. [R-WY-At Large] · [R-WY-0] · H001096 · Co-sponsored 2026-04-14
    Rep-WY current · 2 terms · @RepHageman · 2 district offices
  • Rep. Stutzman, Marlin A. [R-IN-3] · [R-IN-3] · S001188 · Co-sponsored 2026-04-14
    Rep-IN-3 current · 5 terms · @RepStutzman · 1 district office
  • Rep. Rogers, Mike D. [R-AL-3] · [R-AL-3] · R000575 · Co-sponsored 2026-04-14
    Rep-AL-3 current · 12 terms · @RepMikeRogersAL · 2 district offices
  • Rep. Kelly, Mike [R-PA-16] · [R-PA-16] · K000376 · Co-sponsored 2026-04-14
    Rep-PA-16 current · 8 terms · @MikeKellyPA · 3 district offices
  • Rep. Hern, Kevin [R-OK-1] · [R-OK-1] · H001082 · Co-sponsored 2026-04-15
    Rep-OK-1 current · 5 terms · @repkevinhern · 1 district office
  • Rep. Kennedy, Mike [R-UT-3] · [R-UT-3] · K000403 · Co-sponsored 2026-04-16
    Rep-UT-3 current · 1 term · @repmikekennedy · 1 district office
  • Rep. Harrigan, Pat [R-NC-10] · [R-NC-10] · H001101 · Co-sponsored 2026-04-16
    Rep-NC-10 current · 1 term · @RepPatHarrigan · 1 district office
  • Rep. Timmons, William R. [R-SC-4] · [R-SC-4] · T000480 · Co-sponsored 2026-04-16
    Rep-SC-4 current · 4 terms · @RepTimmons · 1 district office
  • Rep. Houchin, Erin [R-IN-9] · [R-IN-9] · H001093 · Co-sponsored 2026-04-16
    Rep-IN-9 current · 2 terms · @RepHouchin · 1 district office
  • Rep. Norman, Ralph [R-SC-5] · [R-SC-5] · N000190 · Co-sponsored 2026-04-16
    Rep-SC-5 current · 5 terms · @RepRalphNorman · 1 district office
  • Rep. Smith, Adrian [R-NE-3] · [R-NE-3] · S001172 · Co-sponsored 2026-04-20
    Rep-NE-3 current · 10 terms · @RepAdrianSmith · 3 district offices
  • Rep. Cline, Ben [R-VA-6] · [R-VA-6] · C001118 · Co-sponsored 2026-04-20
    Rep-VA-6 current · 4 terms · @RepBenCline · 4 district offices
  • Rep. Bean, Aaron [R-FL-4] · [R-FL-4] · B001314 · Co-sponsored 2026-04-21
    Rep-FL-4 current · 2 terms · @RepAaronBean · 3 district offices
  • Rep. Clyde, Andrew S. [R-GA-9] · [R-GA-9] · C001116 · Co-sponsored 2026-04-21
    Rep-GA-9 current · 3 terms · @Rep_Clyde · 1 district office
  • Rep. Steube, W. Gregory [R-FL-17] · [R-FL-17] · S001214 · Co-sponsored 2026-04-21
    Rep-FL-17 current · 4 terms · @RepGregSteube · 3 district offices
  • Rep. Messmer, Mark B. [R-IN-8] · [R-IN-8] · M001233 · Co-sponsored 2026-04-21
    Rep-IN-8 current · 1 term · 2 district offices
  • Rep. Cammack, Kat [R-FL-3] · [R-FL-3] · C001039 · Co-sponsored 2026-04-21
    Rep-FL-3 current · 3 terms · @RepKatCammack · 1 district office
  • Rep. Onder, Robert F. [R-MO-3] · [R-MO-3] · O000177 · Co-sponsored 2026-04-22
    Rep-MO-3 current · 1 term · @RepBobOnder · 2 district offices
  • Rep. McGuire, John J. [R-VA-5] · [R-VA-5] · M001239 · Co-sponsored 2026-04-27
    Rep-VA-5 current · 1 term · @RepJohnMcGuire · 1 district office
  • Rep. Hill, J. French [R-AR-2] · [R-AR-2] · H001072 · Co-sponsored 2026-04-28
    Rep-AR-2 current · 6 terms · @RepFrenchHill · 2 district offices
  • Rep. Wilson, Joe [R-SC-2] · [R-SC-2] · W000795 · Co-sponsored 2026-05-12
    Rep-SC-2 current · 13 terms · @RepJoeWilson · 2 district offices
  • Rep. Crank, Jeff [R-CO-5] · [R-CO-5] · C001137 · Co-sponsored 2026-05-12
    Rep-CO-5 current · 1 term · @RepJeffCrank · 1 district office
  • Rep. Walberg, Tim [R-MI-5] · [R-MI-5] · W000798 · Co-sponsored 2026-05-13
    Rep-MI-5 current · 9 terms · @RepWalberg · 2 district offices
  • Rep. Langworthy, Nicholas A. [R-NY-23] · [R-NY-23] · L000600 · Co-sponsored 2026-06-03
    Rep-NY-23 current · 2 terms · @RepLangworthy · 4 district offices
  • Rep. Downing, Troy [R-MT-2] · [R-MT-2] · D000634 · Co-sponsored 2026-06-23
    Rep-MT-2 current · 1 term · @reptroydowning · 2 district offices
  • Rep. Pfluger, August [R-TX-11] · [R-TX-11] · P000048 · Co-sponsored 2026-07-13
    Rep-TX-11 current · 3 terms · @RepPfluger · 6 district offices
  • Rep. Fischbach, Michelle [R-MN-7] · [R-MN-7] · F000470 · Co-sponsored 2026-07-14
    Rep-MN-7 current · 3 terms · @RepFischbach · 2 district offices
  • Rep. Harshbarger, Diana [R-TN-1] · [R-TN-1] · H001086 · Co-sponsored 2026-07-20
    Rep-TN-1 current · 3 terms · @RepHarshbarger · 2 district offices
  • Rep. Tenney, Claudia [R-NY-24] · [R-NY-24] · T000478 · Co-sponsored 2026-07-20
    Rep-NY-24 current · 4 terms · @RepTenney · 4 district offices
  • Rep. Davidson, Warren [R-OH-8] · [R-OH-8] · D000626 · Co-sponsored 2026-07-27
    Rep-OH-8 current · 6 terms · @WarrenDavidson · 2 district offices
  • Rep. Mills, Cory [R-FL-7] · [R-FL-7] · M001216 · Co-sponsored 2026-07-27
    Rep-FL-7 current · 2 terms · @RepMillsPress · 2 district offices
  • Rep. Patronis, Jimmy [R-FL-1] · [R-FL-1] · P000622 · Co-sponsored 2026-08-06
    Rep-FL-1 current · 1 term · 2 district offices
  • Rep. Bilirakis, Gus M. [R-FL-12] · [R-FL-12] · B001257 · Co-sponsored 2026-09-01
    Rep-FL-12 current · 10 terms · @RepGusBilirakis · 3 district offices
  • Rep. Bergman, Jack [R-MI-1] · [R-MI-1] · B001301 · Co-sponsored 2026-09-01
    Rep-MI-1 current · 5 terms · @RepJackBergman · 2 district offices
  • Rep. Babin, Brian [R-TX-36] · [R-TX-36] · B001291 · Co-sponsored 2026-09-01
    Rep-TX-36 current · 6 terms · @RepBrianBabin · 4 district offices
  • Rep. Gosar, Paul A. [R-AZ-9] · [R-AZ-9] · G000565 · Co-sponsored 2026-09-01
    Rep-AZ-9 current · 8 terms · @RepGosar · 1 district office
  • Rep. Estes, Ron [R-KS-4] · [R-KS-4] · E000298 · Co-sponsored 2026-09-01
    Rep-KS-4 current · 5 terms · @RepRonEstes · 1 district office
  • Rep. Simpson, Michael K. [R-ID-2] · [R-ID-2] · S001148 · Co-sponsored 2026-09-01
    Rep-ID-2 current · 14 terms · @CongMikeSimpson · 3 district offices
  • Rep. Goldman, Craig A. [R-TX-12] · [R-TX-12] · G000601 · Co-sponsored 2026-09-01
    Rep-TX-12 current · 1 term · @RepCraigGoldman · 1 district office
  • Rep. McDowell, Addison P. [R-NC-6] · [R-NC-6] · M001240 · Co-sponsored 2026-09-01
    Rep-NC-6 current · 1 term · @RepMcDowell · 1 district office
  • Rep. Fine, Randy [R-FL-6] · [R-FL-6] · F000484 · Co-sponsored 2026-09-01
    Rep-FL-6 current · 1 term · 2 district offices
  • Rep. Biggs, Andy [R-AZ-5] · [R-AZ-5] · B001302 · Co-sponsored 2026-09-02
    Rep-AZ-5 current · 5 terms · @RepAndyBiggsAZ · 1 district office
  • Rep. Griffith, H. Morgan [R-VA-9] · [R-VA-9] · G000568 · Co-sponsored 2026-09-02
    Rep-VA-9 current · 8 terms · @RepMGriffith · 2 district offices
  • Rep. Stauber, Pete [R-MN-8] · [R-MN-8] · S001212 · Co-sponsored 2026-09-03
    Rep-MN-8 current · 4 terms · @RepPeteStauber · 4 district offices
  • Rep. Boebert, Lauren [R-CO-4] · [R-CO-4] · B000825 · Co-sponsored 2026-09-04
    Rep-CO-4 current · 3 terms · @RepBoebert · 2 district offices
  • Rep. Moran, Nathaniel [R-TX-1] · [R-TX-1] · M001224 · Co-sponsored 2026-09-04
    Rep-TX-1 current · 2 terms · @RepNateMoran · 4 district offices
  • Rep. Baird, James R. [R-IN-4] · [R-IN-4] · B001307 · Co-sponsored 2026-10-15
    Rep-IN-4 current · 4 terms · @RepJimBaird · 1 district office
  • Rep. Murphy, Gregory F. [R-NC-3] · [R-NC-3] · M001210 · Co-sponsored 2026-10-15
    Rep-NC-3 current · 4 terms · @RepGregMurphy · 4 district offices
  • Rep. Yakym, Rudy [R-IN-2] · [R-IN-2] · Y000067 · Co-sponsored 2026-10-22
    Rep-IN-2 current · 3 terms · @RepRudyYakym · 2 district offices
  • Rep. Issa, Darrell [R-CA-48] · [R-CA-48] · I000056 · Co-sponsored 2026-10-22
    Rep-CA-48 current · 12 terms · @repdarrellissa · 3 district offices
  • Rep. Fuller, Clay [R-GA-14] · [R-GA-14] · F000485 · Co-sponsored 2026-10-26
    Rep-GA-14 current · 1 term
  • Rep. Rulli, Michael A. [R-OH-6] · [R-OH-6] · R000619 · Co-sponsored 2026-10-26
    Rep-OH-6 current · 2 terms · 2 district offices
  • Rep. Reschenthaler, Guy [R-PA-14] · [R-PA-14] · R000610 · Co-sponsored 2026-10-29
    Rep-PA-14 current · 4 terms · @GReschenthaler · 2 district offices
  • Rep. Roy, Chip [R-TX-21] · [R-TX-21] · R000614 · Co-sponsored 2026-11-09
    Rep-TX-21 current · 4 terms · @RepChipRoy · 3 district offices
  • Rep. Gill, Brandon [R-TX-26] · [R-TX-26] · G000603 · Co-sponsored 2026-11-10
    Rep-TX-26 current · 1 term · @repbrandongill · 1 district office
  • Rep. Jack, Brian [R-GA-3] · [R-GA-3] · J000311 · Co-sponsored 2026-11-12
    Rep-GA-3 current · 1 term · @RepBrianJack · 1 district office

Committees (1)

  • Energy and Commerce Committee [House Standing]
    2025-01-23T15:04:35ZReferred To

Actions — from XML (3)

  • 2025-01-23IntroReferralH11100via House floor actions
    Referred to the House Committee on Energy and Commerce.
  • 2025-01-23IntroReferralIntro-Hvia Library of Congress
    Introduced in House
  • 2025-01-23IntroReferral1000via Library of Congress
    Introduced in House

Actions — from bill_actions table (0)

none

Titles

  • Display Title2026-11-10T14:14:58Z
    SAVE Moms and Babies Act of 2025
  • Short Title(s) as IntroducedIH2025-02-25T05:08:18Z
    SAVE Moms and Babies Act of 2025
  • Short Title(s) as IntroducedIH2025-02-25T05:08:18Z
    Support And Value Expectant Moms and Babies Act of 2025
  • Official Title as IntroducedIH2025-02-25T05:03:23Z
    To amend the Federal Food, Drug, and Cosmetic Act to prohibit the approval of new abortion drugs, to prohibit investigational use exemptions for abortion drugs, and to impose additional regulatory requirements with respect to previously approved abortion drugs, and for other purposes.

Text versions (from XML)

Versions — from bill_versions table (0)

none

Policy area

Health

Summaries

00 · 2025-01-23 · Introduced in House

Support And Value Expectant Moms and Babies Act of 2025 or the SAVE Moms and Babies Act of 2025

This bill prohibits the Food and Drug Administration (FDA) from approving any new drug (either as a brand-name drug or a generic) intended to terminate a pregnancy and imposes additional restrictions on such drugs that are already approved.

Under the bill, an already-approved drug intended to terminate a pregnancy may be dispensed to a patient only with a prescription. Furthermore, the FDA may not approve any labeling change that would authorize (1) using the drug after 70 days of gestation, or (2) dispensing the drug by any means other than in-person administration by the prescribing health care practitioner.

The FDA must also impose additional restrictions on such already-approved drugs, including by (1) requiring the prescribing health care practitioner to receive a special certification, (2) prohibiting the practitioner from also acting as the dispensing pharmacist, and (3) requiring the practitioner to have the ability to provide surgical intervention to the patient.

The bill also rescinds any investigational use exemption already granted to such a drug if the bill would have prohibited the FDA from granting the exemption. (Currently, the FDA may grant an exemption to certain market approval requirements if a drug is intended solely for use in safety and effectiveness investigations.)

Related bills

  • S 3697 (119) SAVE Moms and Babies Act of 2026
    Latest: 2026-01-27 — Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S292)
    Relationship: Related bill (via CRS)

Amendments (0)

none

Laws

none

Committee reports

none

Calendar number

null

CBO cost estimates

none

Latest action

Date
2025-01-23
Text
Referred to the House Committee on Energy and Commerce.
Time
null

Dublin Core

format
text/xml
language
EN
rights
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
contributor
Congressional Research Service, Library of Congress
description
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.

Row fields (debug)

id
655
congress
119
bill_type
hr
bill_number
685
bill_slug
hr-685-119
title
SAVE Moms and Babies Act of 2025
short_title
SAVE Moms and Babies Act of 2025
sponsor_bioguide_id
L000566
sponsor_name
Rep. Latta, Robert E. [R-OH-5]
sponsor_party
R
sponsor_state
OH
introduced_date
2025-01-23
latest_action_date
2025-01-23
latest_action_text
Referred to the House Committee on Energy and Commerce.
status
Committee
policy_area
Health
subjects_json
[
  "Abortion",
  "Drug safety, medical device, and laboratory regulation",
  "Health information and medical records",
  "Health personnel",
  "Health technology, devices, supplies",
  "Marketing and advertising",
  "Prescription drugs"
]
govinfo_billstatus_path
BILLSTATUS-119hr685
raw_billstatus_xml
<?xml version="1.0" encoding="utf-8" standalone="no"?> <billStatus> <version>3.0.0</version> <bill> <number>685</number> <updateDate>2026-11-13T09:06:48Z</updateDate> <updateDateIncludingText>2026-11-13T09:06:48Z</updateDateIncludingText> <originChamber>House</originChamber> <originChamberCode>H</originChamberCode> <type>HR</type> <introducedDate>2025-01-23</intr…
summary_lede
Support And Value Expectant Moms and Babies Act of 2025 or the SAVE Moms and Babies Act of 2025 This bill prohibits the Food and Drug Administration (FDA) from approving any new drug (either as a brand-name drug or a generic) intended to terminate a pregnancy and imposes additional restrictions on such drugs that are already approved. Under the bill, an already-approved drug intended to termina…
topic_primary
health
topic_secondary_json
[]
action_family
committee_active
response_available
0
response_type
null
response_deadline
null
importance_score
null
consequence_score
null
urgency_score
null
overall_score
null
in_canopy
0
canopy_expires_at
null
pipeline_track
federal_presidential
pipeline_stage
introduced
pipeline_stage_rank
3
stable_action_id
hr-685-119
jurisdiction
federal
lock_status
open
lock_at
null
content_hash
14682dbd428a57beb5b1012d296e2ed2af180d8674106e4de7233a76987f7ffb
anchored_at
null
anchor_merkle_root
null
source_kind
api_fill
first_seen_at
2026-04-20T08:15:57.988066+00:00
last_seen_at
2026-11-18T12:30:05.902845+00:00
⎔ Anchored0x0000…0000Epoch 2026-Q4